Search our Innovation Portfolio

QP-Prostate® is a Software as a Medical Device (SaMD) designed to assist radiologists in reporting prostate MRI for patients suspected of having clinically significant prostate cancer (csPCa). Using T2w and DWI series from bpMRI/mpMRI studies, QP-Prostate® employs Artificial Intelligence (AI) to automatically identify and segment suspicious regions of interest (ROIs) for csPCa, providing confidence levels (High and Moderate) overlaid on axial T2w images for radiologist review. The software is trained and validated using biopsy outcomes (both targeted and systematic) as the ground truth, encompassing data from biopsy-naïve patients and those under active surveillance.

HELP Flag includes a laboratory-based alert for routine primary care blood tests that have high platelet counts, and provides an evidence-based pathway for GPs to triage patients with raised platelets.

Prostate Intelligence™ (Pi™) is AI-based medical device software to support the diagnosis of prostate cancer. It automatically analyses prostate MRI scans, outlining lesions and calculating risk scores and volumes. Pi™ is used to assist radiologists to quickly identify patients at low risk who can avoid a painful, invasive biopsy, and to locate possible lesions so that higher-risk patients can have a targeted biopsy to maximise the chance of finding cancers that need treatment.